🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07253376
Enrolling by invitation Observational

Turkish Validation of the Parkinson Disease Cognitive Functional Rating Scale

NCT07253376 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-10-10
Last updated
2026-03-19

Condition(s) studied

CognitionParkinson's DiseaseReliability and ValidityCognitive FunctionsCognitive Functioning

Study summary

The aim of the present study is to translate the Parkinson's Disease-Cognitive Functional Rating Scale into Turkish (PD-CFRS-Turkish version) and to evaluate its validity and reliability.

Eligibility

Sex
ALL
Min age
40 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Clinically diagnosed with idiopathic Parkinson's disease by a neurologist. * Evaluated between Stage 1-3 according to the Hoehn and Yahr Staging Scale. * Aged 40 years or older. * Agreed to participate in the study after being given sufficient information. Exclusion Criteria: * Patients with a Montreal Cognitive Assessment score of 20 and below. * Patients with cardiovascular, vestibular, musculoskeletal or additional neurological disease.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Gazi University, Faculty of Health Sciences Ankara Turkey (Türkiye)
Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital Ankara Turkey (Türkiye)

More Gazi University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07253376 on ClinicalTrials.gov ↗ ← All trials in Turkey